Titon Holdings Plc (LON:TON – Get Free Report)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 73.05 ($0.99) and traded as high as GBX 83 ($1.13). Titon shares last traded at GBX 83 ($1.13), with a volume of 171 shares changing hands.
Analyst Ratings Changes
Separately, Shore Capital reissued a “house stock” rating on shares of Titon in a research note on Wednesday, April 30th.
Get Our Latest Report on Titon
Titon Stock Performance
Titon (LON:TON – Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported GBX (1.44) (($0.02)) earnings per share for the quarter. Titon had a negative return on equity of 7.84% and a negative net margin of 5.06%. As a group, equities analysts expect that Titon Holdings Plc will post 9.2847318 earnings per share for the current year.
Insider Transactions at Titon
In other news, insider Tom Carpenter acquired 13,806 shares of Titon stock in a transaction dated Friday, May 9th. The stock was bought at an average cost of GBX 72 ($0.98) per share, with a total value of £9,940.32 ($13,533.45). 63.72% of the stock is owned by insiders.
About Titon
Titon Holdings Plc is a leading international manufacturer and supplier of ventilation systems and window and door hardware with a reputation for quality products and high levels of customer service. Formed in 1972 we employ over 150 people in the UK and operate in the USA. Titon is listed on the AIM Market on the London Stock Exchange, ticker is “TON”.
Titon has a strong presence in the UK residential ventilation market with a comprehensive range of mechanical and natural ventilation products and is also a leading supplier of window and door hardware.
Read More
- Five stocks we like better than Titon
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- A Deeper Look at Bid-Ask Spreads
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Titon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titon and related companies with MarketBeat.com's FREE daily email newsletter.